• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Migraine

The AJMC® Migraine compendium is a comprehensive resource for clinical news and expert insights for the recurring type of headache, which is accompanied by side effects.

Latest News

AJMC original research clinical
Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

November 18th 2025

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine.

AJMC original research clinical
Coverage With Evidence Development Study Shows Benefits in Patients With Migraine Treated With Remote Electrical Neuromodulation

April 8th 2025

Migraine vice  | Image Credit: © Andrii Zastrozhnov-stock.adobe.com
Optimizing Episodic Migraine Care: ACP’s Latest Treatment Guidance

February 3rd 2025

Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists

April 20th 2023

Image of a hurting perosn
Care for Migraine Insufficient in Germany, Online Survey Finds

March 25th 2022

More News

© 2026 MJH Life Sciences
AJMC®
All rights reserved.